Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|5|551-572

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.5, 2015-02, pp. : 551-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Approaches in the Treatment of Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 13-28

Bentham Science Publishers

Access to resources Recommend Favorite

PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

By Doggrell Sheila A   Hancox Jules C  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 867-871

Informa Healthcare

Access to resources Recommend Favorite

The immediate future for the medical treatment of atrial fibrillation

By Pedersen Ole Dyg   Brendorp Bente   Køber Lars   Torp-Pedersen Christian  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 259-268

Informa Healthcare

Access to resources Recommend Favorite

Assessment of Quality of Life in Pharmacological Treatment of Atrial Fibrillation

By  

Heart Drug, Vol. 3, Iss. 1, 2003-07 ,pp. : 14-24

Karger

Access to resources Recommend Favorite

Atrial-selective sodium channel block for the treatment of atrial fibrillation

By Burashnikov Alexander   Antzelevitch Charles  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 233-249

Informa Healthcare

Access to resources Recommend Favorite